LDS/Medical Tests/Biopsy, Brain

Biopsy, Brain

Brain biopsy is a procedure in which a sample of tissue is obtained from the brain parenchyma, meninges or other intracranial structures. The procedure is performed either under local anesthesia with intravenous sedation or general anesthesia. Although frame-based stereotactic methods are widely used, frameless stereotaxy is currently emerging as an effective alternative. A post-operative non-contrast head computed tomography (CT) scan is obtained to assess the site of biopsy and clinically relevant hemorrhage, if any. Generally, the patient is admitted to the hospital for an overnight observation.

The procedure involves placement of a stereotactic frame (for frame-based methods), identifying the target lesion by a contrast-enhanced CT scan or T2-weighted magnetic resonance imaging (MRI) in case of low-grade gliomas. This facilitates planning the trajectory and entry site to avoid major vascular structures and functionally important areas of the brain. The scalp entry site is prepared and the patient is then transferred to the operating room for the biopsy. A diagnostic specimen is obtained and sent to the neuropathologist for further work-up.

There are no universal standards to assess adequacy of the size of the brain biopsy. The amount of tissue that can be biopsied varies from patient to patient and is generally dependent on the size and location of the lesion, radiologic diagnosis, and vascularity, and is at the discretion of the neurosurgeon. Potential complications of the procedure include hemorrhage and obtaining non-diagnostic specimen which often prompts re-biopsy. Relative contraindications include uncontrollable coagulopathy, altered mental status resulting in poor patient cooperation, vascular malformations and highly-vascular tumors such as metastatic melanoma, and other medical conditions affecting surgical/anesthetic fitness.

Brian biopsy is usually performed for diagnosis go primary brian and central nerve system tumors such as glioma, meningioma, and lymphoma; diagnosis of metastatic brain tumors of known/unknown primaries such as carcinoma and melanoma as well as diagnosis of cryptogenic neurologic diseases such as suspected primary angiitis of the central nervous system (PACNS), amyloidosis and other related brain diseases.

  • Diagnosis of primary CNS tumors
  • Diagnosis of metastatic brain tumors of known/unknown primaries
  • Rarely in the diagnosis of cryptogenic neurologic diseases such as suspected primary angiitis of the central nervous system (PACNS)
Histopathologic interpretation of a brain biopsy is dependent on the clinical presentation, radiologic findings, and site of the biopsy.

There are no universal reference ranges for brain biopsies. In general, a normal brain shows variation in the architecture and cellular compositions with appropriate anatomic sites.

Depending the amount of specimen obtained for pathologic examination, touch preparation, squash preparation, and cut sections of the formalin-fixed paraffin embedded tissue are obtained for hematoxylin-eosin staining. Immunohistochemical staining, cytogenetic tests such as fluorescent in-situ hybridization (FISH) studies, and molecular diagnostic tests (loss of heterozygosity, point mutation analysis, next-generation sequencing) may be performed at the discretion of the neuropathologist.

Biopsies are obtained by a neurosurgeon. Specimens are sent fresh to histopathologic examination in clean containers. Evaluation of the specimen often requires an adequacy assessment by a pathologist at the time of biopsy (intraoperatively). Generally, the neuropathologist triages the specimen for further testing (touch imprints, squash preparations, intraoperative frozen section analysis, formalin fixation for permanent tissue sections, etc.). Uncommonly, in cases of suspected CNS infections, a culture is indicated and tissue for culture should be sent in a sterile container to the laboratory. Immunohistochemical staining, FISH studies and molecular diagnostic tests can be performed on the formalin-fixed paraffin-embedded tissue.

Lumbar puncture for cerebrospinal fluid (CSF) analysis.
Usually 24 hours for routine light microscopy, possibly longer if immunohistochemical staining and ancillary studies are indicated.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login